// App-Quantinova.ai

P2-01-13 : Prognostic Value of Circulating Tumor Cells Count at Progressive Disease after First Line Chemotherapy Metastatic Breast Patients in a Large Prospective Multicenter Trial Including Serum Tumor Markers (IC 2006-04 Study)

Researchers

Presenter

  • Pierga J-Y

Principal Investigators

  • Hajage D

  • Bachelot T

  • Delaloge S

  • Campone M

  • Asselain B

  • Cottu PH

  • Dieras V

  • Bidard F-C

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved